News

Pseudophakic patients may benefit from a fluocinolone acetonide intravitreal implant (Iluvien, Alimera Sciences), the company tells a United Kingdom committee.

A cellular-level adaptive optics retinal camera (rtx1, Imagine Eyes) has received CE mark approval in the European Union.

A new sealant (ReSure, Ocular Therapeutix) will be studied for clear corneal incision closure after cataract extraction or IOL placement.

Improved efficacy and dosing convenience are the aims of a new drug delivery system incorporating a cationic polymer and formulated with ketorolac.

New data presented at the European Society of Retina Specialists meeting suggest that ranibizumab is effective in patients with AMD, DME, and RVO.

Newly published research gives ophthalmologists a reason to encourage their adult patients with visual field loss in both eyes to be more physically active.

Mark Dlugoss, Ophthalmology Times editor-in-chief, is blogging daily from ESCRS. Today he discusses the attendance of Latin American physicians at ESCRS.

Ophthalmology Times editor-in-chief, Mark Dlugoss, is blogging daily from ESCRS. Today he discusses various releases of intraocular lenses (IOLs).

Ophthalmology Times Editor-in-Chief, Mark Dlugoss, blogs daily from the 2012 congress of the European Society of Cataract and Refractive Surgeons (ESCRS).

Glaucoma and age-related macular degeneration (AMD) research grants have been awarded to Wilmer Eye Institute by the American Health Assistance Foundation.

The Welch Allyn facility in Beaverton, OR, earned Leadership in Energy and Environmental Design (LEED) certification from the U.S. Green Building Council.

William M. Moore has been named interim president and chief executive officer of Iridex Corp. Moore succeeds Dominik Beck.

Implantable contact lens and preloaded IOL manufacturing will move to California in a consolidation project now under way at STAAR Surgical.

Glaucoma may be a significant predictor of depression, according to research published in the American Journal of Ophthalmology.

The FDA approved OptiMedica's Catalys Precision for creating single-plane and multi-plane arc incisions in the cornea during cataract surgery.

A trifocal diffractive intraocular lens (FineVision IOL, PhysIOL) reduces spectacle dependence after cataract surgery and provides patient satisfaction.

Ocular Therapeutix Inc. is initiating a phase II clinical trial of OTX-TP2, a 2-month travoprost punctum plug for treating ocular hypertension and glaucoma.

Allergan Inc. and Molecular Partners AG have entered into two agreements to discover, develop, and commercialize proprietary therapeutic designed ankyrin repeat protein (DARPin) products for the treatment of opthalmic diseases.

Gevokizumab, an IL-1 beta-modulating antibody from XOMA Corp., has received FDA orphan drug designation for the treatment of several types of non-infectious uveitis.

Ophthalmologists will have a new way to learn about advances in laser surgery next year, thanks to a $1 million donation made to the American Academy of Ophthalmology.

Educating the public about cataract risk factors, detection, and treatment options has been the goal of the American Academy of Ophthalmology (AAO) EyeSmart program during August, Cataract Awareness Month.

The Foundation Fighting Blindness is funding projects related to age-related macular degeneration, retinitis pigmentosa, Leber's congenital amaurosis, and Usher syndrome.

Fibrin glue might be a potential cause of toxic anterior segment syndrome (TASS).

A study found that accommodative changes in the central anterior chamber depth (ACD) of patients with high myopia were less pronounced than emmetropic eyes.

A short video of capsulotomy creation with the VICTUS femtosecond laser.

Allergan and Molecular Partners AG have expanding their relationship with two new agreements for DARPin products.

The Joint Commission on Allied Health Personnel in Ophthalmology (JCAHPO) and Pearson VUE partner to provide ophthalmic medical techs access to simulated exams.

Insight Software, creators of My Vision Express, has been ranked by Inc. magazine as one of the nation's fastest-growing private companies.